The activation of SERINC5, a serine incorporator, is intricately tied to the modulation of intracellular signaling pathways, particularly those governed by the second messenger cyclic adenosine monophosphate (cAMP). Activation of adenylate cyclase by certain small molecules leads to a surge in cAMP levels within the cell. This rise in cAMP is crucial for the enhanced insertion of SERINC5 into the plasma membrane, a process central to its functional activity. The elevation of cAMP is further sustained by the inhibition of phosphodiesterase enzymes, which normally degrade cAMP. By preventing this degradation, these inhibitors ensure a continuous signal for SERINC5 activation, thereby potentiating its serine incorporation capabilities. Furthermore, the activation of protein kinase C via other small molecules can initiate phosphorylation cascades that may promote SERINC5's incorporation into cellular membranes, highlighting the multifaceted nature of its regulation.
Alongside these cAMP-centric mechanisms, SERINC5 activity is also influenced by alterations in intracellular calcium concentrations. Compounds that function as calcium ionophores can elevate the levels of intracellular calcium, which may serve as a signal to facilitate SERINC5-mediated serine incorporation, indicating a role for calcium-dependent signaling in SERINC5 function. The dynamic interplay between cAMP levels and calcium signaling creates a concerted network of biochemical events that underlie the activation of SERINC5.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-selective phosphodiesterase inhibitor that prevents cAMP degradation, potentially sustaining SERINC5 activity through cAMP pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C, which may lead to phosphorylation events that promote SERINC5 incorporation into cellular membranes. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophore that raises intracellular calcium, possibly facilitating SERINC5-mediated serine incorporation in response to calcium signals. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Membrane-permeable cAMP analog that can enhance SERINC5 activity by mimicking cAMP's effect on cellular signaling. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore that increases intracellular calcium concentration potentially enhancing SERINC5 function in calcium-dependent pathways. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
cAMP analog that activates cAMP-dependent pathways, potentially promoting the activity of SERINC5. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
Phosphodiesterase 3 inhibitor that increases cAMP levels, potentially sustaining SERINC5 function. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Phosphodiesterase 4 inhibitor that could enhance cAMP levels, indirectly increasing SERINC5 function. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
β-adrenergic agonist that can raise cAMP levels, possibly resulting in increased SERINC5 activity. | ||||||